دورية أكاديمية

Enhanced expression of WD repeat-containing protein 35 (WDR35) stimulated by domoic acid in rat hippocampus: involvement of reactive oxygen species generation and p38 mitogen-activated protein kinase activation

التفاصيل البيبلوغرافية
العنوان: Enhanced expression of WD repeat-containing protein 35 (WDR35) stimulated by domoic acid in rat hippocampus: involvement of reactive oxygen species generation and p38 mitogen-activated protein kinase activation
المؤلفون: Tsunekawa Koji, Kondo Fumio, Okada Teruhiko, Feng Guo-Gang, Huang Lei, Ishikawa Naohisa, Okada Shoshiro
المصدر: BMC Neuroscience, Vol 14, Iss 1, p 4 (2013)
بيانات النشر: BMC, 2013.
سنة النشر: 2013
المجموعة: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
LCC:Neurophysiology and neuropsychology
مصطلحات موضوعية: Domoic acid, WDR35, Hippocampus, AMPA/KA receptor, ROS, p38 MAPK, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurophysiology and neuropsychology, QP351-495
الوصف: Abstract Background Domoic acid (DA) is an excitatory amino acid analogue of kainic acid (KA) that acts via activation of glutamate receptors to elicit a rapid and potent excitotoxic response, resulting in neuronal cell death. Recently, DA was shown to elicit reactive oxygen species (ROS) production and induce apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) in vitro. We have reported that WDR35, a WD-repeat protein, may mediate apoptosis in several animal models. In the present study, we administered DA to rats intraperitoneally, then used liquid chromatography/ion trap tandem mass spectrometry (LC-MS/MS) to identify and quantify DA in the brains of the rats and performed histological examinations of the hippocampus. We further investigated the potential involvement of glutamate receptors, ROS, p38 MAPK, and WDR35 in DA-induced toxicity in vivo. Results Our results showed that intraperitoneally administered DA was present in the brain and induced neurodegenerative changes including apoptosis in the CA1 region of the hippocampus. DA also increased the expression of WDR35 mRNA and protein in a dose- and time-dependent manner in the hippocampus. In experiments using glutamate receptor antagonists, the AMPA/KA receptor antagonist NBQX significantly attenuated the DA-induced increase in WDR35 protein expression, but the NMDA receptor antagonist MK-801 did not. In addition, the radical scavenger edaravone significantly attenuated the DA-induced increase in WDR35 protein expression. Furthermore, NBQX and edaravone significantly attenuated the DA-induced increase in p38 MAPK phosphorylation. Conclusion In summary, our results indicated that DA activated AMPA/KA receptors and induced ROS production and p38 MAPK phosphorylation, resulting in an increase in the expression of WDR35 in vivo.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2202
العلاقة: http://www.biomedcentral.com/1471-2202/14/4Test; https://doaj.org/toc/1471-2202Test
DOI: 10.1186/1471-2202-14-4
الوصول الحر: https://doaj.org/article/3cf978d719494058b5a25f87f1f716afTest
رقم الانضمام: edsdoj.3cf978d719494058b5a25f87f1f716af
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712202
DOI:10.1186/1471-2202-14-4